Myocardial Assistance by Grafting a New Bioartificial Upgraded Myocardium (MAGNUM Trial): Clinical Feasibility Study

Annals of Thoracic Surgery

Volumn 85, Issue 3, 2008, Pages 901-908

  Chachques, Juan C ^a   Trainini, Jorge C ^b   Lago, Noemi ^a   Cortes Morichetti, Miguel ^a   Schussler, Olivier ^a   Carpentier, Alain ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b Avellaneda Hospital   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; COLLAGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; ARTIFICIAL HEART; BIOARTIFICIAL ORGAN; BONE MARROW CELL; CARDIOMYOPATHY; CARDIOMYOPLASTY; CELL REGENERATION; CELL TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIASTOLIC BLOOD PRESSURE; EXTRACELLULAR MATRIX; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEART MUSCLE ISCHEMIA; HEART STRESS; HEART VENTRICLE FILLING; HEART VENTRICLE REMODELING; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MORTALITY; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SCAR FORMATION; TISSUE ENGINEERING; TISSUE REGENERATION;

ABSORBABLE IMPLANTS; BONE MARROW TRANSPLANTATION; CARDIAC SURGICAL PROCEDURES; COLLAGEN TYPE I; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; TISSUE SCAFFOLDS;

EID: 39349108880     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2007.10.052     Document Type: Article

References (46)

1. Hierlihy A.M., Seale P., Lobe C.G., Rudnicki M.A., and Megeney L.A. The post-natal heart contains a myocardial stem cell population. FEBS Lett 530 (2002) 239-243
2. Linke A., Muller P., Nurzynska D., et al. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci USA 102 (2005) 8966-8971
3. Matsuura K., Nagai T., Nishigaki N., et al. Adult cardiac sca-1-positive cells differentiate into beating cardiomyocytes. J Biol Chem 279 (2004) 11384-11391
4. Oh H., Bradfute S.B., Gallardo T.D., et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA 100 (2003) 12313-12318
5. Urbanek K., Quaini F., Tasca G., et al. Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc Natl Acad Sci USA 100 (2003) 10440-10445
6. Pellegrini G., Dellambra E., Golisano O., et al. p63 identifies keratinocyte stem cells. Proc Natl Acad Sci USA 98 (2001) 3156-3161
7. Jaffredo T., Nottingham W., Liddiard K., Bollerot K., Pouget C., and de Bruijn M. From hemangioblast to hematopoietic stem cell: an endothelial connection?. Exp Hematol 33 (2005) 1029-1040
8. Sanai N., Alvarez-Buylla A., and Berger M.S. Neural stem cells and the origin of gliomas. N Engl J Med 353 (2005) 811-822
9. Messina E., De Angelis L., Frati G., et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 95 (2004) 911-921
10. Poss K.D., Wilson L.G., and Keating M.T. Heart regeneration in zebrafish. Science 298 (2002) 2188-2190
11. Bettencourt-Dias M., Mittnacht S., and Brockes J.P. Heterogeneous proliferative potential in regenerative adult newt cardiomyocytes. J Cell Sci 116 (2003) 4001-4009
12. Pfeffer M.A., and Braunwald E. Ventricular remodelling after myocardial infarction. Experimental observations and clinical implications. Circulation 81 (1990) 1161-1172
13. Laflamme M.A., and Murry C.E. Regenerating the heart. Nat Biotechnol 23 (2005) 845-856
14. Rajnoch C., Chachques J.C., Berrebi A., Bruneval P., Benoit M.O., and Carpentier A. Cellular therapy reverses myocardial dysfunction. J Thorac Cardiovasc Surg 121 (2001) 871-878
15. Chachques J.C., Acar C., Herreros J., et al. Cellular cardiomyoplasty: clinical application. Ann Thorac Surg 77 (2004) 1121-1130
16. Stamm C., Kleine H.D., Choi Y.H., et al. Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J Thorac Cardiovasc Surg 133 (2007) 717-725
17. Assmus B., Honold J., Schachinger V., et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 355 (2006) 1222-1232
18. Schachinger V., Erbs S., Elsasser A., et al., REPAIR-AMI Investigators. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355 (2006) 1210-1221
19. Meyer G.P., Wollert K.C., Lotz J., et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration trial). Circulation 113 (2006) 1287-1294
20. Janssens S., Dubois C., Bogaert J., et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 367 (2006) 113-121
21. Lunde K., Solheim S., Aakhus S., et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 355 (2006) 1199-1209
22. Teng C.J., Luo J., Chiu R.C., and Shum-Tim D. Massive mechanical loss of microspheres with direct intramyocardial injection in the beating heart: implications for cellular cardiomyoplasty. J Thorac Cardiovasc Surg 132 (2006) 628-632
23. Brown L. Cardiac extracellular matrix: a dynamic entity. Am J Physiol Heart Circ Physiol 289 (2005) H973-H974
24. Piao H., Kwon J.S., Piao S., et al. Effects of cardiac patches engineered with bone marrow-derived mononuclear cells and PGCL scaffolds in a rat myocardial infarction model. Biomaterials 28 (2007) 641-649
25. Barandon L., Couffinhal T., Dufourcq P., et al. Repair of myocardial infarction by epicardial deposition of bone-marrow-cell-coated muscle patch in a murine model. Ann Thorac Surg 78 (2004) 1409-1417
26. Zimmermann W.H., Melnychenko I., Wasmeier G., et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 12 (2006) 452-458
27. Christman K.L., and Lee R.J. Biomaterials for the treatment of myocardial infarction. J Am Coll Cardiol 48 (2006) 907-913
28. Cortes-Morichetti M., Frati G., Schussler O., et al. Association between a cell-seeded collagen matrix and cellular cardiomyoplasty for myocardial support and regeneration. Tissue Eng 13 (2007) 2681-2687
29. Kutschka I., Chen I.Y., Kofidis T., et al. Collagen matrices enhance survival of transplanted cardiomyoblasts and contribute to functional improvement of ischemic rat hearts. Circulation 114 Suppl (2006) I167-I173
30. Chachques J.C., Herreros J., Trainini J., et al. Autologous human serum for cell culture avoids the implantation of cardioverter-defibrillators in cellular cardiomyoplasty. Int J Cardiol 95 Suppl 1 (2004) 29-33
31. Schiller N., Shah P., Crawford M., et al. American Society of Echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms: recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 2 (1989) 358-367
32. Herpel E., Pritsch M., Koch A., Dengler T.J., Schirmacher P., and Schnabel P.A. Interstitial fibrosis in the heart: differences in extracellular matrix proteins and matrix metalloproteinases in end-stage dilated, ischaemic and valvular cardiomyopathy. Histopathology 48 (2006) 736-747
33. Lunkenheimer P.P., Redmann K., Westermann P., et al. The myocardium and its fibrous matrix working in concert as a spatially netted mesh: a critical review of the purported tertiary structure of the ventricular mass. Eur J Cardiothorac Surg 29 Suppl 1 (2006) 41-49
34. Kresh J.Y. Cell replacement therapy: the functional importance of myocardial architecture and intercellular gap-junction distribution. J Thorac Cardiovasc Surg 131 (2006) 1310-1313
35. Eschenhagen T., and Zimmermann W.H. Engineering myocardial tissue. Circ Res 97 (2005) 1220-1231
36. Leor J., Landa N., and Cohen S. Renovation of the injured heart with myocardial tissue engineering. Expert Rev Cardiovasc Ther 4 (2006) 239-252
37. Kofidis T., de Bruin J.L., Hoyt G., et al. Myocardial restoration with embryonic stem cell bioartificial tissue transplantation. J Heart Lung Transplant 24 (2005) 737-744
38. Giraud M.N., Armbruster C., Carrel T., and Tevaearai H.T. Current state of the art in myocardial tissue engineering. Tissue Eng 13 (2007) 1825-1836
39. Fedak P.W., Szmitko P.E., Weisel R.D., et al. Cell transplantation preserves matrix homeostasis: a novel paracrine mechanism. J Thorac Cardiovasc Surg 130 (2005) 1430-1439
40. Tang Y.L., Zhao Q., Qin X., et al. Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. Ann Thorac Surg 80 (2005) 229-237
41. Kubal C., Sheth K., Nadal-Ginard B., and Galinanes M. Bone marrow cells have a potent anti-ischemic effect against myocardial cell death in humans. J Thorac Cardiovasc Surg 132 (2006) 1112-1118
42. Thum T., Bauersachs J., Poole-Wilson P.A., Volk H.D., and Anker S.D. The dying stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle. J Am Coll Cardiol 46 (2005) 1799-1802
43. Ebelt H., Jungblut M., Zhang Y., et al. Cellular cardiomyoplasty: improvement of left ventricular function correlates with the release of cardioactive cytokines. Stem Cells 25 (2007) 236-244
44. Chachques J.C., Duarte F., Cattadori B., et al. Angiogenic growth factors and/or cellular therapy for myocardial regeneration: a comparative study. J Thorac Cardiovasc Surg 128 (2004) 245-253
45. Chachques J.C., Salanson-Lajos C., Lajos P., Shafy A., Alshamry A., and Carpentier A. Cellular cardiomyoplasty for myocardial regeneration. Asian Cardiovasc Thorac Ann 13 (2005) 287-296
46. Dzau V.J., Gnecchi M., and Pachori A.S. Enhancing stem cell therapy through genetic modification. J Am Coll Cardiol 46 (2005) 1351-1353